# Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption
Canonical URL: https://biopharmsignal.com/news/BNGO/bionano-announces-67-year-over-year-growth-in-studies-featuring-optical-genome-mapping-at-eshg-2026-reflecting-expanding-global-adoption
Ticker: BNGO
Company: BioNano Genomics
Source: BioNano Genomics
Published: 2026-06-25 13:46 EST
Original Source URL: https://ir.bionanogenomics.com
## Summary

SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) conference grew substantially compared to the conference in 2025, consistent with expanding

## Article Body
SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) conference grew substantially compared to the conference in 2025, consistent with expanding
## Recent Company News
- 2026-06-25 13:46 EST — [Bionano Announces Hiring of Chief Scientific Officer](https://biopharmsignal.com/news/BNGO/bionano-announces-hiring-of-chief-scientific-officer) — Source: BioNano Genomics
- 2026-06-25 13:46 EST — [Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption](https://biopharmsignal.com/news/BNGO/bionano-announces-67-year-over-year-growth-in-studies-featuring-optical-genome-mapping-at-eshg-2026-reflecting-expanding-global-adoption) — Source: BioNano Genomics
- 2026-06-25 13:46 EST — [Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders](https://biopharmsignal.com/news/BNGO/bionano-announces-multiple-publications-in-2026-describing-unique-utility-of-ogm-in-studies-of-reproductive-health-and-prenatal-genetic-disorders) — Source: BioNano Genomics
- 2026-06-25 13:46 EST — [Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures](https://biopharmsignal.com/news/BNGO/bionano-announces-full-retirement-of-outstanding-senior-secured-convertible-debentures) — Source: BioNano Genomics
- 2026-06-25 13:46 EST — [Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia](https://biopharmsignal.com/news/BNGO/bionano-announces-largest-ogm-study-of-t-cell-acute-lymphoblastic-leukemia) — Source: BioNano Genomics
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)